Related Experiment Video
Updated: Jul 12, 2026
09:07
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Electroconvulsive therapy use in pregnancy
Muzaffer Kasar1, Omer Saatcioglu, Tarik Kutlar
1Bakirkoy Research and Training Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey.
The Journal of ECT
|September 7, 2007
Summary
Electroconvulsive therapy (ECT) is a safe psychiatric treatment during pregnancy when risks are managed. This case study examines premature labor in a patient who received ECT.
Area of Science:
- Obstetrics and Gynecology
- Psychiatry
- Perinatology
Background:
- Pregnancy presents unique challenges for managing psychiatric disorders.
- Electroconvulsive therapy (ECT) is a viable treatment option during pregnancy.
- Careful risk mitigation is essential for safe ECT in pregnant patients.
Observation:
- This article details a case involving premature labor.
- The patient underwent electroconvulsive therapy (ECT) during pregnancy.
- The focus is on the interplay between ECT and obstetric outcomes.
Findings:
- Electroconvulsive therapy (ECT) can be safely administered during pregnancy.
- Potential risks associated with ECT in pregnancy require careful management.
- Premature labor is a critical consideration in pregnant patients undergoing ECT.
Implications:
- ECT can be a crucial therapeutic option for severe psychiatric conditions in pregnant individuals.
- Clinicians must be vigilant in monitoring for and managing obstetric complications.
- Further research into optimizing ECT protocols for pregnant patients is warranted.
Related Concept Videos
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...